DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Rinke A. et al.
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival.

Neuroendocrinology 2017;
104: 26-32

Download Bibliographical Data

Search in:
Access: